Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/12792
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChaichompoo W.
dc.contributor.authorChokchaisiri R.
dc.contributor.authorApiratikul N.
dc.contributor.authorChairoungdua A.
dc.contributor.authorYingyongnarongkul B.-E.
dc.contributor.authorChunglok W.
dc.contributor.authorTocharus C.
dc.contributor.authorSuksamrarn A.
dc.date.accessioned2021-04-05T03:21:37Z-
dc.date.available2021-04-05T03:21:37Z-
dc.date.issued2018
dc.identifier.issn10542523
dc.identifier.other2-s2.0-85034226641
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/12792-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85034226641&doi=10.1007%2fs00044-017-2115-3&partnerID=40&md5=7376199d05ae06e5a7172fae5d8cdeeb
dc.description.abstractPhytochemical investigation of the CHCl3 extract of the seed embryos of Nelumbo nucifera Gaertn resulted in the isolation of a new naturally occurring bisbenzylisoquinoline alkaloid, O-methylneferine (1), together with five known alkaloids, neferine (2), armepavine (3), (–)-(1R)-N-methylcoclaurine (4), nuciferine (5), and pronuciferine (6). The structures of these compounds were characterized by spectroscopic methods and comparison of physical properties with those reported in the literature. Among them, compounds 1 and 2 exhibited significant activity against human colon adenocarcinoma cell line (HT-29), with IC50 values of 0.70 and 1.61 µM, respectively, which were 8- and 3.5-fold higher than that of the reference anticancer drug, doxorubicin (IC50 5.63 µM). Moreover, compounds 1 and 2 displayed less cytotoxic activity against the non-cancerous HEK 239 cells with the IC50 values of 42.48 and 12.19 μM, respectively, whereas the cytotoxicity of doxorubicin against this cell line was 0.22 μM. The very potent cytotoxicity against HT-29 cell line and very high selectivity index (60.6-fold) of the alkaloid 1 is of particular significant; it could be considered as a promising structure lead for anti-colon cancer drug development. © 2017, Springer Science+Business Media, LLC, part of Springer Nature.
dc.subjectalkaloid
dc.subjectarmepavine
dc.subjectcytotoxic agent
dc.subjectdoxorubicin
dc.subjectn methylcoclaurine
dc.subjectneferine
dc.subjectNelumbo nucifera extract
dc.subjectnuciferine
dc.subjecto methylneferine
dc.subjectpronuciferine
dc.subjectunclassified drug
dc.subjectArticle
dc.subjectcolon adenocarcinoma
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectdrug isolation
dc.subjectdrug potency
dc.subjectdrug selectivity
dc.subjectdrug structure
dc.subjectHEK293 cell line
dc.subjectHT-29 cell line
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC50
dc.subjectNelumbo nucifera
dc.subjectnonhuman
dc.subjectphytochemistry
dc.subjectplant seed
dc.titleCytotoxic alkaloids against human colon adenocarcinoma cell line (HT-29) from the seed embryos of Nelumbo nucifera
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationMedicinal Chemistry Research. Vol 27, No.3 (2018), p.939-943
dc.identifier.doi10.1007/s00044-017-2115-3
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.